RxDoctor Payments Data

Pamela West

Pediatrics · Lincoln, NENPI 1215922281

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 53 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 14.9% — the pattern of someone who eats at a lot of different presentations.

$1,012in general payments, 2019–2025

Across 53 payments — averaging $19.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Tris Pharma Inc$151
  • Merck$148
  • Ironshore Pharmaceuticals Inc.$84
  • Pfizer$81
  • Seqirus USA Inc$62
  • Takeda Pharmaceuticals U.S.A., Inc.$60
  • plus $425 from 15 others
$262,734in research payments, 2019–2025

Across 53 payments — averaging $4957.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • GSK$263K

What the payments were for

  • Food & beverage$1,012100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,012 in reported general payments places this provider in the 80th percentile of 308 pediatrics providers in Nebraska.

See all pediatrics providers in Nebraska

Other pediatrics in Lincoln

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →